These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Factors on graft survival of living donor kidney transplantation in a single center. Jin DC; Yoon YS; Kim YS; Yoon SA; Ahn SJ; Kim SY; Chang YS; Bang BK; Koh YB Clin Transplant; 1996 Dec; 10(6 Pt 1):471-7. PubMed ID: 8996765 [TBL] [Abstract][Full Text] [Related]
5. Living related donor renal transplantation in Semarang, Indonesia (1985 to 1991). Shofa C; Soewito A; Darmono E; Hendro W; Lysiani S; Purwanto ; Chandra M; Faik H; Rifki M; Parsudi AI Transplant Proc; 1992 Oct; 24(5):1813. PubMed ID: 1412858 [No Abstract] [Full Text] [Related]
7. Single center experience of 1000 primary living donor kidney transplants: univariate and multivariate analysis of risk factors affecting graft survival. Park K; Kim YS; Oh CK; Lee HY; Han DS; Lee JS; Kim PK Transplant Proc; 1994 Aug; 26(4):2159-60. PubMed ID: 8066708 [No Abstract] [Full Text] [Related]
8. Donor specific transfusions: a five-year experience with alternative protocols. Norman DJ; Henell K; Fletcher L; Barry J Transplant Proc; 1987 Feb; 19(1 Pt 3):2252-4. PubMed ID: 3274504 [No Abstract] [Full Text] [Related]
9. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes. Øien CM; Reisaeter AV; Leivestad T; Dekker FW; Line PD; Os I Transplantation; 2007 Mar; 83(5):600-6. PubMed ID: 17353781 [TBL] [Abstract][Full Text] [Related]
10. No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience. Brynger H; Persson H; Flatmark A; Albrechtsen D; Frödin L; Tufvesson G; Gäbel H; Weibull H; Möller E; Lundgren G Transplant Proc; 1988 Jun; 20(3 Suppl 3):261-3. PubMed ID: 3291253 [No Abstract] [Full Text] [Related]
11. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients. Kerman RH; Van Buren CT; Lewis RM; Kahan BD Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254 [No Abstract] [Full Text] [Related]
12. Effect of donor-specific transfusions on renal transplantation in children. Potter D; Garovoy M; Hopper S; Terasaki P; Salvatierra O Pediatrics; 1985 Sep; 76(3):402-5. PubMed ID: 3162150 [TBL] [Abstract][Full Text] [Related]
13. Living-related and living-unrelated kidney transplantation using low-dose triple immunosuppression. Francis DM; Walker RG; Millar RJ; Becker G Transplant Proc; 1992 Oct; 24(5):1887-8. PubMed ID: 1412899 [No Abstract] [Full Text] [Related]
14. Significance of the donor age effect on kidney transplants. Terasaki PI; Gjertson DW; Cecka JM; Takemoto S; Cho YW Clin Transplant; 1997 Oct; 11(5 Pt 1):366-72. PubMed ID: 9361925 [TBL] [Abstract][Full Text] [Related]
15. Concomitant immunosuppression and donor-specific transfusions prior to renal transplantation. Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA Transplant Proc; 1989 Feb; 21(1 Pt 2):1828-31. PubMed ID: 2652594 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of some donor-recipient HLA-DR mismatches on cadaveric graft survival: proposal for a new selection policy of recipients. Vereerstraeten P; Andrien M; De Pauw L; Dupont E; Goldman M; Abramowicz D; Kinnaert P Transplant Proc; 1991 Feb; 23(1 Pt 1):385-6. PubMed ID: 1990560 [No Abstract] [Full Text] [Related]
18. Donor nonspecific blood transfusions before renal transplantation from haplo-mismatched living related donors. Shapira Z; Zamir R; Livni E; Yussim A; Shmueli D; Yehoshua H Transplant Proc; 1989 Feb; 21(1 Pt 2):1834-5. PubMed ID: 2652596 [No Abstract] [Full Text] [Related]
19. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants. Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888 [No Abstract] [Full Text] [Related]